# Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes

> **NCT05778383** · PHASE4 · COMPLETED · sponsor: **Parc de Salut Mar** · enrollment: 75 (actual)

## Conditions studied

- Zinc Deficiency
- Sars-CoV-2 Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Zinc Acetate

## Key facts

- **NCT ID:** NCT05778383
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2022-02-23
- **Final completion:** 2022-05-25
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05778383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05778383, "Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05778383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*